Wells Fargo Downgrades YM BioSciences (YMI) to Market Perform
Tweet
Share
E-mailGet Alerts YMI Hot Sheet
Price: $2.94 --0%
Rating Summary:
2 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 3
Rating Summary:
2 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 3
Join SI Premium – FREE
Wells Fargo downgraded YM BioSciences (NYSE: YMI) from Outperform to Market Perform with a $2.50-$3.50 valuation range after the company was acquired in a deal announced earlier.
For an analyst ratings summary and ratings history on YM BioSciences click here. For more ratings news on YM BioSciences click here.
Shares of YM BioSciences closed at $1.63 yesterday.
For an analyst ratings summary and ratings history on YM BioSciences click here. For more ratings news on YM BioSciences click here.
Shares of YM BioSciences closed at $1.63 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kepler Cheuvreux Downgrades Carl Zeiss Meditec AG (AFXG:GR) (CZMWY) to Reduce
- UBS Downgrades FANUC Corp (6954:JP) (FANUY) to Neutral
- JPMorgan Downgrades TRONOX (TROX) to Underweight
Create E-mail Alert Related Categories
DowngradesRelated Entities
Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
